The phrase "active implants" is correct and usable in written English.
It can be used in contexts related to medical devices or technology that are designed to be implanted in the body and actively perform functions.
Example: "The development of active implants has revolutionized the treatment of chronic conditions, allowing for real-time monitoring and intervention."
Alternatives: "implanted devices" or "functional implants".
Active implants such as pacemakers and implantable cardioverter defibrillators (ICDs) need to relay information to other devices for control or monitoring [2].
Nowadays, they are being developed as active implants with the ability to prevent failures by loosening.
The development of active implants thus allows their potential use in the context of dental engineering.
Active implants placed within the human body lead to better and faster diagnosis, thus improving the patient's quality of life.
Active implants placed within the human body lead to better and faster diagnosis, thus, improving the quality of life of the patient.
The use of active implants allows vital medical data to be collected over a longer period in the natural environment of the patient, allowing for a more accurate and sometimes even faster diagnosis.
Together, these findings suggest that multi-layered, microfabricated PGS scaffolds may be applicable to myocardial repair applications requiring mechanical support, cell delivery and active implant contractility.
In other words, an active implant surface provides the required conditions for starting the desired interaction with the cellular environment.
In pigs, calculated CSF/peripheral venous plasma ratio was 1.31 ± 1.34 on day 5 and 0.886 ± 0.255 on day 7. Correspondingly in dogs receiving active implant, after one hour in 5 × 8,5 mg nimodipine group, the CSF/jugular plasma ratio was 0.002 ± 0.0005 and in 8,5 mg nimodipine group 0.149 ± 0.174.
Moderate toughness and poor biological features of ceramics may hinder their application as modern bio-active implants.
Patients implanted with any active implantable medical device other than a left-sided single or dual chamber implantable cardioverter defibrillator (ICD) with bipolar sensing, amended to add other than a left-sided CRT device with each sensing channel programmed to either bipolar sensing or no sensing.
